Introducing new Head of Research & Development

Since April 1, 2023, Dr. Kai Prager has been joining DiaSys Diagnostic Systems as Head of R&D. Dr. Prager is German citizen and offers more than 15 years of experience in the diagnostic sector. His focus is on developing innovative diagnostic test systems in the field of autoimmune diseases and other disorders, which comprises the whole value chain from biomarker development to the registered IVD product.

His background in biology, biochemistry and cell biology, along with his experience as Senior Manager R&D Autoimmune Diagnostics at AESKU Group will certainly contribute to DiaSys' further success.

Dr. Kai Prager
Prof. Dr. Matthias Grimmler

In 2022, Professor Matthias Grimmler decided to leave his position at DiaSys, however, within a two years transition period during which he will still take over responsibility for several current DiaSys projects until June 2023, and gradually hand over all responsibilities to Dr. Prager. As of July 2024, Prof. Grimmler will dedicate his time exclusively to the new assignment as Head Customer Business Care and Head New Technologies and Products and as Co-CEO of DiaServe Laboratories. In 2016, DiaSys acquired a participation in DiaServe with regard to producing controls, calibrators, and processed human specimen material.

In addition to heading DiaSys’ R&D since 2015, Professor Grimmler has been appointed professor of immunology and clinical chemistry at the University of Applied Science Fresenius, Idstein, Germany, where he routinely lectures these topics and supervises a variety of practical students as well as bachelor and master activities in DiaSys R&D every year. Along with his work at University Fresenius, he will continue to support and represent DiaSys and DiaServe by scientific publications and within the International Federation of Clinical Chemistry (IFCC).

DiaSys hopes to continue and extend this academic collaboration with the University of Applied Science Fresenius in the future with Dr. Prager.

DiaSys welcomes Dr. Prager and thanks Professor Grimmler - extending best wishes for a pleasant new beginning to both of them within DiaSys group and DiaServe.